Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Thrombolytic drug

A technology of thrombolytic and thrombus medicine, which is applied in the field of traditional Chinese medicine preparations, can solve the problems of poor treatment effect of cerebral thrombosis and insignificant improvement of symptoms, achieve safety without obvious toxic side effects, relieve hand and foot flexion and extension, and treat thrombotic diseases Effect

Active Publication Date: 2020-10-13
HEILONGJIANG UNIV OF CHINESE MEDICINE
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to solve the problem that the existing traditional Chinese medicine preparations are not effective in treating thrombosis, especially in the treatment of cerebral thrombosis, the effect on improving symptoms is not significant, and the current thrombus removal device is rarely used in combination with auxiliary thrombus-clearing agents. Thrombolytic drug and thrombus removal spraying device

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Thrombolytic drug
  • Thrombolytic drug
  • Thrombolytic drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0037] Embodiment: A kind of thrombolytic medicine of the present embodiment, by 45g salvia miltiorrhiza, 20g Uncaria vine, 20g Herba chinensis, 20g Prunella vulgaris, 12g earthworm, 10g safflower, 15g peach kernel, 15g mulberry branch, 15g orange branch, 15g Composed of pine branches, 15g peach branches, 15g fir branches, 15g bamboo branches and 3g licorice.

[0038] The above-mentioned medicine is decocted and extracted with water (Uncaria is added in the later stage of decoction), filtered, and the filtrate is collected to make a medicine type suitable for clinical use.

[0039] Select 60 cases of patients with acute cerebral infarction and randomly divide them into a Chinese medicine treatment group of 30 cases and a conventional treatment group of 30 cases. In the traditional Chinese medicine treatment group, there were 18 males and 12 females, aged 51 to 75 years, with an average of (64.53±5.44) years old. In the conventional treatment group, there were 17 males and 13 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a thrombolytic drug, relates to the field of traditional Chinese medicine preparations, and aims to solve the problems that an existing traditional Chinese medicine preparationis poor in treatment effect on thrombus, particularly cerebral thrombosis treatment effect and symptom improvement effect, and an existing thrombus removal device is rarely combined with an auxiliarythrombus removal agent for use. The thrombolytic drug is prepared from 30-60 parts of radix salviae miltiorrhizae, 15-30 parts of ramulus uncariae cum uncis, 15-25 parts of herba siegesbeckiae, 15-25parts of spica prunellae, 10-15 parts of lumbricus, 10-15 parts of flos carthami, 15-25 parts of semen persicae, 15-25 parts of ramulus mori, 15-25 parts of orange twig, 15-25 parts of pine twig, 15-25 parts of peach twig, 15-25 parts of fir twig. 25 parts of bamboo branches and 2-5 parts of radix glycyrrhizae. The invention is applied to treatment of thrombotic diseases.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine preparations, in particular to a thrombolytic drug. Background technique [0002] Thrombotic diseases are diseases caused by thrombosis and thromboembolism, such as myocardial infarction, cerebral thrombosis, deep vein thrombosis, cerebral embolism, pulmonary embolism, etc. Thrombotic disease is a disease with high morbidity and mortality, which seriously threatens people's health. Therefore, dissolving the formed thrombus has become an important method for the clinical treatment of thrombotic diseases. [0003] The theory of collateral disease in traditional Chinese medicine believes that "collateral blood stasis", that is, coronary arteriosclerosis in modern medicine causes myocardial ischemia, long-term chest tightness and chest pain, and "collateral veins are urgent", which is what modern medicine calls coronary artery disease. Spasm, so that the attack of coronary heart disease a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61P7/02A61B17/22A61M25/00A61K35/62A61K31/351
CPCA61B17/22A61B2017/22038A61B2017/22079A61B2017/22084A61K31/351A61K35/62A61K36/13A61K36/15A61K36/28A61K36/286A61K36/484A61K36/536A61K36/537A61K36/605A61K36/736A61K36/74A61K36/752A61K36/899A61M25/0043A61M2025/0057A61P7/02A61K2300/00
Inventor 刘宏袁瑶薇周明佳鄂延林
Owner HEILONGJIANG UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products